Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan.

about

Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan.

Item

http://www.wikidata.org/entity/Q55341968

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Safety, Effectiveness, and Tre ...... ld Clinical Practice in Japan.

@en

Safety, Effectiveness, and Tre ...... ld Clinical Practice in Japan.

@nl

type

Item

label

Safety, Effectiveness, and Tre ...... ld Clinical Practice in Japan.

@en

Safety, Effectiveness, and Tre ...... ld Clinical Practice in Japan.

@nl

prefLabel

Safety, Effectiveness, and Tre ...... ld Clinical Practice in Japan.

@en

Safety, Effectiveness, and Tre ...... ld Clinical Practice in Japan.

@nl

P1476

Safety, Effectiveness, and Tre ...... ld Clinical Practice in Japan.

@en

P2093

Hirohito Shimizu

http://www.w3.org/2001/XMLSchema#string

Hisanori Kobayashi

http://www.w3.org/2001/XMLSchema#string

Masayoshi Kanbori

http://www.w3.org/2001/XMLSchema#string

Tsutomu Yajima

http://www.w3.org/2001/XMLSchema#string

Yutaka Ishii

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

The pathogenesis of rheumatoid arthritis

Estimates of the prevalence of and current treatment practices for rheumatoid arthritis in Japan using reimbursement data from health insurance societies and the IORRA cohort (I).

Shared decision-making for biologic treatment of autoimmune disease: influence on adherence, persistence, satisfaction, and health care costs.

Cardiovascular morbidity and mortality in rheumatoid arthritis.

Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence.

Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study

Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis.

Determinants of treatment adherence in ethnically diverse, economically disadvantaged patients with rheumatic disease.

P2888

s40744-018-0101-y

P304

135-148

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40744-018-0101-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Masateru Okazaki

P577

2018-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101318396

http://www.w3.org/2001/XMLSchema#string

P698

29500791

http://www.w3.org/2001/XMLSchema#string

P932

5935614

http://www.w3.org/2001/XMLSchema#string